Psilocybin

A study on rats suggests that microdosing psilocybin could reduce stress-induced anhedonia and compulsive behaviors without causing anxiety or schizophrenia-like symptoms. This research offers insights into psilocybin's potential as a therapy for mental health disorders, though further human studies are...

A recent neuroimaging study shows psilocybin, found in magic mushrooms, significantly alters brain connectivity in alcohol-dependent rats. This mirrors effects seen in humans, offering new avenues for researching the therapeutic impact of psychedelics.

Scientists have discovered that rapid-acting antidepressants like ketamine, psilocybin, and scopolamine can alter negative mood biases in rodent models, a symptom common in depressive disorders. This breakthrough, published in Science Translational Medicine, suggests new approaches to treat Major Depressive Disorder...

A study analyzed Reddit posts to investigate how psilocybin affects self-perception and recognition in mirror gazing, finding it tends to enhances positive self-perception without impairing self-recognition.

Recent psychedelic research shows promising results for mental illnesses and eating disorders, with surveys and reports indicating psilocybin-assisted therapy's potential. However, challenges in research methodology, patient safety concerns, and the need for cautious optimism highlight the gap between scientific evidence...

Psilocybin-assisted group therapy might help reduce depression in cancer patients. This innovative approach, blending psychedelic effects with psychological support, has demonstrated promising results in improving mental health and quality of life for these patients.

Scientists at Enveric Biosciences have created novel psilocybin derivatives, potentially offering therapeutic mental health benefits with reduced psychedelic effects. This research paves the way for new treatments for depression and anxiety.

Research from Toronto Western Hospital shows psilocybin-assisted psychotherapy as a promising treatment for major depression and cancer-related distress, calling for urgent advanced clinical trials. This innovative approach combines psychedelic mushrooms with guided therapy, offering new hope in mental health.

New research suggests a single dose of psilocybin, combined with psychotherapy, could significantly reduce depression in individuals with bipolar II disorder, maintaining these effects for 12 weeks. This innovative approach, contrasting sharply with self-medication, highlights the potential of controlled psychedelic...

A new study has found a link between psilocybin use and lowered psychological distress, particularly in individuals with adverse childhood experiences, highlighting the possible therapeutic applications of psychedelics.

New research in the Journal of Humanistic Psychology found that individuals who've used psilocybin have strong antidepressant expectations, especially those with profound experiences like emotional breakthroughs. However, they expect less impact on motivation and sleep disturbances. The study emphasizes the...

A recent multi-site study published in the Journal of the American Medical Association revealed that psilocybin-assisted therapy offers rapid and sustained antidepressant effects for individuals with major depressive disorder. Compared to an active placebo, the treatment improved psychosocial functioning and...

A recent scientific study has uncovered an intriguing connection between the use of psilocybin, the psychoactive compound found in certain "magic" mushrooms, and reduced overtime work among full-time employees. While the study's findings aren't conclusive proof of causation, they shed...

In a phase II clinical trial, a single dose of psilocybin, combined with SSRI treatment and supportive therapy, showed promising safety and therapeutic outcomes for individuals with treatment-resistant depression. While the results suggest that SSRIs do not inhibit the potential...

A recent study published in the Journal of Psychopharmacology suggests that psilocybin, the active component in "magic mushrooms", can induce lasting neuroplastic changes in the brain, which are associated with improvements in symptoms of depression. The research, which found significant...